Loading clinical trials...
Loading clinical trials...
Treatment Efficacy for Drug Abuse and AIDS Prevention
The purpose of this study is to assess the safety and effectiveness of buprenorphine for treatment of concurrent intravenous heroin and cocaine dependence.
Age
26 - 41 years
Sex
MALE
Healthy Volunteers
No
McLean Hospital, Dept. of Psychiatry
Belmont, Massachusetts, United States
Start Date
September 1, 1989
Primary Completion Date
February 1, 1996
Completion Date
February 1, 1996
Last Updated
January 12, 2017
Buprenorphine
DRUG
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
NCT04155632
NCT02773212
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT01999946